FDA Alerts Providers to Defibrillator Recall
Phillips Electronics North America Corp. has recalled 71 HeartStart MRx defibrillators produced in September and October 2016 due to a defect that may cause the device to fail, the Food and Drug Administration announced Friday. If used in automated external defibrillator mode after failing, the device will not delivery patient therapy, which may lead to serious patient injury or death, the agency said. For more information and a list of affected devices, see the FDA notice.
Related News Articles
Headline
In this conversation, Terry Scoggin, CEO of Titus Regional Medical Center, discusses how the organization designed a system of care to ensure that every…
Headline
In this AHA blog Aisha Syeda, senior program manager for AHA’s Strategic Initiatives, summarizes five action steps hospitals can take to establish pediatric…
Blog
In 2024, the U.S. suffered 24 weather and climate disasters. In October alone, two major hurricanes devastated communities in North Carolina and Florida,…
Headline
In this “Safety Speaks” conversation, CommonSpirit Health's Beth Miller, system director, patient safety-performance improvement, and Austin Peterson, system…
Headline
In this conversation, Oren Guttman, M.D., anesthesiologist and vice president of High Reliability & Patient Safety at Thomas Jefferson University,…
Headline
In this conversation, Jennifer Richards, Ph.D., assistant professor at the Center for Indigenous Health, Johns Hopkins Bloomberg School of Public Health, and…